Fabasoft AG
FBSFF · XETRA
About FBSFF
- Employees
- 505
- Headquarters
- Linz, Oberoesterreich
- Listed
- Oct 1, 1999
- Sector
- Information Technology
- Industry
- Software
- Website
- fabasoft.com
FBSFF key statistics
- Market cap
- 177.10M
- Price-earnings ratio
- 14.36
- Dividend yield
- 0.61%
- Average volume
- 7.54K
- Volume
- 120
- Open price
- $18.75
- High today
- $18.75
- Low today
- $18.75
- 52 Week high
- $17.95
- 52 Week low
- $10.30
Fabasoft AG (FBSFF) at a glance
Fabasoft AG (FBSFF) last traded at $18.75, with a market cap of 177.10M, a price-to-earnings ratio of 14.36 and a dividend yield of 0.61%.
Volume so far is 120 shares, below the average of 7.54K shares a day.
Over the past year Fabasoft AG has ranged from $10.30 to $17.95, and now sits 110% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.